Although the question of which source of galectin-1 (tumour hepatocytes or HSCs) contributes more to the progression of HCC has not been answered definitively, our results suggested that HSC-derived galectin-1 promotes HCC progression at least in part by affecting T cells. This evidence concerns the gene LGALS1 and neoplasm.